202 Followers on Owler
Denali is a California-based biotechnology company that develops molecular therapeutics for the treatment of neurodegenerative diseases... Read more
OverviewCompetitorsFundingNews & Insights
Denali is a California-based biotechnology company that develops molecular therapeutics for the treatment of neurodegenerative diseases... Read more
Denali Therapeutics President & CEO: Ryan Watts

President & CEO

Ryan Watts

CEO Approval Rating

94/100

2013

PublicNASDAQDNLI

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$330.5M
Employees
430
Funding
$2.2B

News

Funding
Dec 06, 2025
Pharamceutical Technology
Denali Therapeutics received $275M in Post-IPO Equity Funding

Denali Therapeutics Competitors

1Alector
2Ionis Pharmaceuticals
3Amylyx
4BioMarin
5Regenxbio
6Homology
7Orchard Therapeutics
8Ultragenyx
9Novartis
10Amgen
Unlock 13 + competitors

Trending Companies